Volume Spike Investor

Xoma Ltd. (NASDAQ: XOMA) is surging on patent news this morning: “XOMA Issued Two New U.S. Patents for Methods of Treating Type 2 Diabetes and Inflammatory Diseases Using Interleukin-1 Beta Antibodies.”  At 8:52 AM EST we have seen 951,000 shares trade hands and the stock is up about 20.5% at $0.82.  The 52-week trading range [...]

EntreMed, Inc. (NASDAQ: ENMD) is up big this morning on reports that it has initiated a Phase II study for its ENMD-2076 in ovarian cancer.  Investors should know that this stock has a history of being all over the place and has been around since the 1990′s as a public company.  It also used to [...]

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) is soaring and soaring his morning as the biggest gainer in some time.  After teh close last night, the company disclosed that results from a completed Phase 2 clinical trial of Onalta were published in the Journal of Clinical Oncology showing that treatment with Onalta improved symptoms associated with [...]

Popular, Inc. (NASDAQ: BPOP), parent of Banco Popular, is one of the most active after disclosing an $85 million loss for its first quarter.  But the company is selling securities in a public offering of  Contingent Convertible Perpetual Non-Cumulative Preferred Stock, Series D, to raise $900 million and FBR Capital Markets initiated coverage this morning [...]

What to do when you see a pairs trade unfold???  Goldman Sachs has come out this morning and said it prefers Expedia Inc. (NASDAQ: EXPE) over Priceline.com Inc. (NASDAQ: PCLN).  Goldman Sachs raised Expedia to its prestigous Conviction Buy List with a $31 target, Priceline.com was cut to Neutral from Buy but its target was [...]

Ambac Financial Group, Inc. (NYSE: ABK) is continuing its run on the heels of last week’s profit after factoring in items.  This had a huge run on Friday on the news, but this reached a silly level yesterday after a 100% rally on top of huge gains seen Friday.  Yet here we are… Shares are [...]

Some of the regional banks are getting hit hard this morning ahead of JPMorgan Chase’s earnings tomorrow.  It sounds like the Duke brothers from Trading Places are out and back in real life this morning… A downgrade is from UBS is hurting the shares this morning in several key stocks because of sell ratings: Huntington [...]

Palm Inc. (NASDAQ: PALM) has reportedly sought out Huawei as a prospective buyer, but there may be one hang up.  The company may be too expensive to acquire now if you factor in the preferred shares and options held by Elevation and private equity investors.  Dow Jones valued that at $1.5 billion if a $6.50 [...]